Exhibit 10.1


 


EXECUTION VERSION


 


PURCHASER SUPPORT AGREEMENT


 


This Purchaser Support Agreement (this “Agreement”)
is effective as of November 16, 2022 by and among (i) Quantum Ventures LLC, a Delaware limited liability company (the “Sponsor
Holdco”), (ii) the Persons set forth on Schedule I hereto (together with the Sponsor Holdco, each, a “Sponsor”
and, together, the “Sponsors”), (iii) Quantum FinTech Acquisition Corporation, a Delaware corporation (“Purchaser”),
and (iv) AtlasClear, Inc., a Wyoming corporation (the “Company”). The Sponsors, Purchaser and the Company and the are
sometimes referred to herein individually as a “Party” and, collectively, as the “Parties”.


 


RECITALS


 


WHEREAS, each Sponsor is the holder of record and
the “beneficial owner” (within the meaning of Rule 13d-3 under the Exchange Act) of the shares of Purchaser Common Stock and
the Purchaser Warrants as set forth opposite such Sponsor’s name on Schedule I attached hereto;


 


WHEREAS, concurrently herewith, Purchaser, the Company,
Calculator New Pubco., Inc., a Delaware corporation and a wholly-owned Subsidiary of Purchaser (“New Pubco”), Calculator Merger
Sub 1, Inc., a Delaware corporation and a wholly-owned Subsidiary of New Pubco (“Merger Sub 1”), Calculator
Merger Sub 2, Inc., a Wyoming corporation and a wholly-owned Subsidiary of New Pubco (“Merger Sub 2” and, collectively
with Merger Sub 1, the “Merger Subs”), Atlas FinTech Holdings Corp. (“Atlas Fintech”) and
Robert McBey are entering into a Business Combination Agreement (as amended, supplemented, restated or otherwise modified from time to
time, the “BCA”; capitalized terms used but not otherwise defined in this Agreement shall have the meanings ascribed
to them in the BCA), pursuant to which (and subject to the terms and conditions set forth therein), (a) Purchaser will merge with and
into Merger Sub 1 (the “First Merger”), with Purchaser being the surviving entity and a wholly owned subsidiary of
New Pubco, and (b) following the First Merger, Merger Sub 2 will merge with and into the Company (the “Second Merger”
and together with the First Merger, the “Mergers”), with the Company being the surviving entity and becoming a wholly
owned subsidiary of New Pubco;


 


WHEREAS, concurrently herewith, the Sponsor Holdco
shall have delivered to the Company a duly executed copy of the Registration Rights and Lock-up Agreement, by and among New PubCo, the
Company, the Sponsor Holdco and certain of the Company’s other shareholders or their respective affiliates, as applicable.


 


WHEREAS, as an inducement to Purchaser and the Company
to enter into the BCA and to consummate the transactions contemplated therein, the Parties desire to agree to certain matters as set forth
herein.


 






     


     


    

 


AGREEMENT


 


NOW, THEREFORE, in consideration of the foregoing
and the mutual agreements contained herein, and intending to be legally bound hereby, the Parties hereby agree as follows:


 


ARTICLE
I

PURCHASER SUPPORT AGREEMENT; COVENANTS; VESTING


 


Section 1.1
Binding Effect of BCA. Each Sponsor hereby acknowledges that it has read the BCA and this Agreement and has had the opportunity
to consult with its tax, legal and other advisors with respect thereto and hereto. Each Sponsor hereby agrees to be bound by and comply
with Section 6.6 (No Solicitation), Section 6.14 (Public Announcements) and Section 6.15 (Confidentiality) of the
BCA (and any relevant definitions contained in such section) as if each such Sponsor was an original signatory to the BCA with respect
to such provisions. Sponsor Holdco further (a) agrees to transfer up to the Purchaser Stock and/or Purchaser Warrants that are held,
directly or indirectly, by Atlas Fintech to potential sources of debt, equity or other financing pursuant to Section 6.19 (Financing)
of the BCA, which transfer shall be effectuated in connection with, and as of immediately prior to, the Closing, and (b) acknowledges
that any Purchaser Common Stock or Purchaser Warrants that remain held, directly or indirectly, by Atlas Fintech as of immediately prior
to the Closing shall automatically be forfeited by Atlas Fintech for no consideration and that Sponsor Holdco shall cause such Purchaser
Common Stock and Purchaser Warrants to be cancelled effective as of the Closing.


 


Section 1.2
No Interim Period Transfers. Each Sponsor shall not, during the Interim Period (except, in each case, pursuant to the BCA
or otherwise consented to by the Company), (i) sell, transfer, hypothecate, pledge, encumber, assign, hedge, swap, convert or otherwise
dispose of (including by merger (including by conversion into securities or other consideration), by tendering into any tender or exchange
offer, by testamentary disposition, by operation of Law or otherwise), either voluntarily or involuntarily, any of its Purchaser Common
Stock or Purchaser Warrants, (ii) enter into any Contract or option with respect to any transaction specified in clause (i) or any swap
or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any of its Purchaser
Common Stock or Purchaser Warrants, whether any such transaction is to be settled by delivery of such securities, in cash or otherwise,
or (iii) publicly announce any intention to effect any transaction specified in clause (i) or (ii) (any transaction specified in clause
(i), (ii) or (iii), a “Transfer”); provided, however, that the foregoing shall not prohibit a Transfer
to any Permitted Transferee (as defined below); provided, further, that any such Transfer shall be permitted only if, as
a precondition to such Transfer, such Permitted Transferee agrees in a writing, reasonably satisfactory in form and substance to the Company,
to assume all of the obligations of the transferor under, and be bound by all of the terms of, this Agreement. Any Transfer in violation
of this Section 1.2 shall be null and void.


 


Section 1.3
New Shares. In the event that (a) any Purchaser Common Stock, Purchaser Warrants or other equity securities of Purchaser
are issued to a Sponsor during the Interim Period pursuant to any stock dividend, stock split, recapitalization, reclassification, combination
or exchange of Purchaser Common Stock or Purchaser Warrants of, on or affecting the Purchaser Common Stock or Purchaser Warrants owned
by such Sponsor or otherwise, (b) a Sponsor purchases or otherwise acquires beneficial ownership of any Purchaser Common Stock, Purchaser
Warrants or other equity securities of Purchaser during the Interim Period, or (c) a Sponsor acquires the right to vote or share in the
voting of any Purchaser Common Stock or other equity securities of Purchaser during the Interim Period (such Purchaser Common Stock, Purchaser
Warrants or other equity securities of Purchaser, collectively the “New Securities”), then such New Securities acquired
or purchased by such Sponsor shall be subject to the terms of this Agreement to the same extent as if they constituted the Purchaser Common
Stock or Purchaser Warrants owned by such Sponsor as of the date hereof. Notwithstanding any of the foregoing to the contrary, and without
limiting Section 1.5(a), no Sponsor shall cause, or permit any Affiliate of Sponsor to cause, any
New Securities to be created or issued except as expressly permitted by the BCA or otherwise consented to by the Company. 


 




    2


     


    

 


Section 1.4
Reserved.


 


Section 1.5
Sponsor Agreements.


 


(a)
During the Interim Period, at any meeting of the shareholders of Purchaser, however called, or at any adjournment thereof, or in
any other circumstance in which the vote, consent or other approval of the shareholders of Purchaser is sought, in each case, as contemplated
by the BCA, each Sponsor shall (i) appear at each such meeting or otherwise cause all of its Purchaser Common Stock to be counted as present
thereat for purposes of calculating a quorum and (ii) vote (or cause to be voted), or execute and deliver a written consent (or cause
a written consent to be executed and delivered) covering, all of its Purchaser Common Stock:


 


(i)
in favor of the transactions contemplated by the BCA, including the Mergers;


 


(ii)
against any Acquisition Proposal or any proposal relating to an Acquisition Proposal (in each case, other than the transactions
contemplated by the BCA, including the Mergers);


 


(iii)
against any merger or business combination agreement or merger (other than the BCA and the Mergers), consolidation, combination,
sale of substantial assets, reorganization, recapitalization, dissolution, liquidation or winding up of or by Purchaser; and


 


(iv)
against any proposal, action or agreement that would or would reasonably be expected to (A) impede, frustrate, prevent or nullify
any provision of this Agreement, the BCA or the Mergers, (B) result in a breach in any respect of any covenant, representation, warranty
or any other obligation or agreement of any party under the BCA or (C) result in any of the conditions set forth in Article VIII of the
BCA not being fulfilled.


 


(b)
Each Sponsor shall comply with, and fully perform all of its obligations, covenants and agreements set forth in, (i) Section 1
of the D&O Insider Letter and (ii) the Sponsor Insider Letter (as applicable) (each as defined below).


 


(c)
During the Interim Period, each Sponsor shall not modify or amend any Contract between or among such Sponsor, anyone related by
blood, marriage or adoption to such Sponsor or any Affiliate of such Sponsor (other than Purchaser), on the one hand, and Purchaser, on
the other hand, including, for the avoidance of doubt, the D&O Insider Letter and the Sponsor Insider Letter (except as expressly
contemplated hereby or by the BCA or the Ancillary Documents).


 


Section 1.6
Reasonable Best Efforts. Without limiting Section 1.5, during the Interim Period, each Sponsor shall (i) take any
action as may reasonably be necessary to satisfy the conditions of the Purchaser set forth in Article VIII of the BCA and (ii) not take
any action that would reasonably be expected to prevent or delay
the satisfaction of any of the conditions to the Mergers and the transactions contemplated by the BCA set forth in Article VIII of the
BCA.


 




    3


     


    

 


Section 1.7
Further Assurances. During the Interim Period, at the Company’s request and without further consideration, each Sponsor
shall execute and deliver, or cause to be executed or delivered, such additional documents and take all such further action as may be
reasonably necessary or required to effect the actions and consummate the transactions contemplated by the BCA and the transactions contemplated
hereby.


 


Section 1.8
No Inconsistent Agreement. Each Sponsor hereby agrees that such Sponsor shall not enter into any agreement that would restrict,
limit, interfere or otherwise be inconsistent with the performance of such Sponsor’s obligations hereunder.


 


Section 1.9
Defined Terms. For purposes of this Agreement:


 


(a)
the term “D&O Insider Letter” means that certain Letter Agreement, dated February 4, 2021, by and among
Purchaser and directors and officers of Purchaser parties thereto;


 


(b)
the term “Existing Registration Rights Agreement” means that certain Registration and Stockholder Rights Agreement,
dated as of February 4, 2021, by and among Purchaser, Sponsor Holdco, Chardan Quantum LLC, a Delaware limited liability company (“Chardan”)
and other Persons parties thereto;


 


(c)
the term “Sponsor Insider Letter” means that certain Letter Agreement, dated February 4, 2021, by and among
Purchaser, Sponsor Holdco and Chardan; and


 


Section 1.10
Waiver of Certain Rights. Each Sponsor hereby irrevocably and unconditionally agrees:


 


(a)
(i) not to (A) demand that Purchaser redeem its or their shares of Purchaser Common Stock in connection with the transactions contemplated
by the BCA, including the Mergers, or (B) otherwise participate in any such redemption by tendering or submitting any of its shares of
Purchaser Common Stock for redemption and (ii) to waive the provisions of Sections 9.2 of the Purchaser Certificate of Incorporation relating
to Redemption Rights (as defined therein);


 


(b)
to waive any anti-dilution or similar protection with respect to any of their Purchaser Common Stock (which for the avoidance of
doubt, shall not include any adjustments to the Private or Public Warrants pursuant to any adjustment mechanism set forth in the Warrant
Agreement);


 


(c)
 (i) that no Working Capital Warrant (as defined in the Warrant Agreement) shall be issued as repayment of any outstanding Working
Capital Loans and (ii) not to demand conversion of any outstanding Working Capital Loans into Working Capital Warrants (as defined in
the Warrant Agreement); and


 


(d)
not to commence or participate in, and to take all actions necessary to opt out of any class in any class action with respect to,
any claim, derivative or otherwise, against Purchaser, the Company, the Company’s or Purchaser’s Affiliates or any of their
respective successors, assigns relating to the negotiation,
execution or delivery of this Agreement, the BCA or the consummation of the transactions contemplated by the BCA, including the Mergers.


 




    4


     


    

 


Section 1.11
Consent to Disclosure. Each Sponsor hereby consents to the publication and disclosure in any announcement or disclosure
required by applicable securities Laws, the SEC or any other securities authorities of such Sponsor’s identity and ownership of
such Sponsor’s Purchaser Common Stock (and New Pubco Common Stock after the Closing) and Purchaser Warrants and the nature of such
Sponsor’s obligations under this Agreement; provided that, prior to any such publication or disclosure the Company and Purchaser
have provided such Sponsor with an opportunity to review and comment upon such announcement or disclosure, which comments the Company
and Purchaser will consider in good faith; provided, further, that the foregoing proviso shall not apply to any such publication
or disclosure the content of which concerning the foregoing does not substantially differ from any prior such publication or disclosure.
Each Sponsor shall promptly provide any information reasonably requested by the Company or Purchaser for any regulatory application or
filing made or approval sought in connection with the transactions contemplated by the BCA, including filings with the SEC, except for
any information that is subject to attorney-client privilege or confidentiality obligations (provided, that with respect to any
confidentiality obligations, such Sponsor, Purchaser and the Company shall cooperate in good faith to enable disclosure of such information
to the maximum extent possible in a manner that complies with such confidentiality obligation).


 


Section 1.12
Termination of Existing Registration Rights. The Registration Rights and Lock-Up Agreement, when executed, shall supersede
the Existing Registration Rights Agreement, which shall be of no further force or effect upon (but subject to the consummation of) the
Closing.


 


ARTICLE
II

REPRESENTATIONS AND WARRANTIES


 


Section 2.1
Representations and Warranties of the Sponsors. Each Sponsor represents and warrants as of the date hereof to the Company
(severally and not jointly and solely with respect to itself, himself or herself and not with respect to any other Sponsor) as follows:


 


(a) Organization;
Due Authorization. If such Sponsor is not an individual, it is duly organized, validly existing and in good standing under the
Laws of the jurisdiction in which it is incorporated, formed, organized or constituted, and the execution, delivery and performance
of this Agreement and the consummation of the transactions contemplated hereby are within such Sponsor’s corporate, limited
liability company or organizational powers and have been duly authorized by all necessary corporate, limited liability company or
organizational actions on the part of such Sponsor. If such Sponsor is an individual, such Sponsor has full legal capacity, right
and authority to execute and deliver this Agreement and to perform his or her obligations hereunder. This Agreement has been duly
executed and delivered by such Sponsor and, assuming due authorization, execution and delivery of this Agreement by each of the
Company and Purchaser, this Agreement constitutes a legally valid and binding obligation of such Sponsor, enforceable against such
Sponsor in accordance with the terms hereof (except as enforceability may be limited by bankruptcy Laws, other similar Laws
affecting creditors’ rights and general principles of equity affecting the availability of specific performance and other
equitable remedies). If this Agreement is being executed in a representative or fiduciary capacity,
the Person signing this Agreement has full power and authority to enter into this Agreement on behalf of the applicable Sponsor.


 




    5


     


    

 


(b) 
Ownership. Such Sponsor is the record and beneficial owner (as defined in the Securities Act) of, and has good title to,
all of such Sponsor’s Purchaser Common Stock and Purchaser Warrants, and there exist no Liens or any other limitation or restriction
(including any restriction on the right to vote, sell or otherwise dispose of such Purchaser Common Stock or Purchaser Warrants (other
than transfer restrictions under the Securities Act)) affecting any such Purchaser Common Stock or Purchaser Warrants, other than Liens
pursuant to (i) this Agreement, (ii) the Purchaser’s Organizational Documents, (iii) the BCA or (iv) any applicable securities
Laws. Such Sponsor’s Purchaser Common Stock and Purchaser Warrants as set forth opposite such Sponsor’s name on Schedule
I hereto are the only equity securities in Purchaser owned of record or beneficially by such Sponsor or such Sponsor’s Affiliates
on the date of this Agreement, and none of such Sponsor’s Purchaser Common Stock or Purchaser Warrants are subject to any proxy,
voting trust or other agreement or arrangement with respect to the voting of such Purchaser Common Stock or Purchaser Warrants, except
as provided hereunder and under the D&O Insider Letter and the Sponsor Insider Letter. Other than the Purchaser Warrants, such Sponsor
does not hold or own any rights to acquire (directly or indirectly) any equity securities of Purchaser or any equity securities convertible
into, or which can be exchanged for, equity securities of Purchaser.


 


(c) 
No Conflicts. The execution and delivery of this Agreement by such Sponsor does not, and the performance by such Sponsor
of his, her or its obligations hereunder will not, (i) if such Sponsor is not an individual, conflict with or result in a violation of
the organizational documents of such Sponsor or if such Sponsor is an individual, conflict with the rights of such Sponsor’s spouse
or domestic partner, as applicable, or (ii) require any consent or approval that has not been given or other action that has not been
taken by any Person (including under any Contract binding upon such Sponsor or such Sponsor’s Purchaser Common Stock or Purchaser
Warrants), in each case, to the extent the absence of such consent, approval or other action would prevent, enjoin or materially delay
the performance by such Sponsor of its, his or her obligations under this Agreement.


 


(d) 
Litigation. As of the date hereof, there are no Actions pending against such Sponsor, or to the knowledge of such Sponsor
threatened against such Sponsor, before (or, in the case of threatened Actions, that would be before) any arbitrator or any Governmental
Authority, which in any manner challenges or seeks to prevent, enjoin or materially delay the performance by such Sponsor of its, his
or her obligations under this Agreement.


 


(e) 
Brokerage Fees. Except as described on Schedule 3.17 of the Purchaser Disclosure Schedules, no broker, finder, investment
banker or other Person is entitled to any brokerage fee, finders’ fee or other commission in connection with the transactions contemplated
by the BCA based upon arrangements made by such Sponsor, for which Purchaser or any of its Affiliates may become liable.


 


(f) Affiliate Arrangements.
Except as set forth on Schedule II attached hereto, no Sponsor nor any anyone related by blood, marriage or adoption to such Sponsor
or, to the knowledge of such Sponsor, any Person in which such Sponsor has a direct or indirect legal, contractual or beneficial ownership
of 5% or greater is party to, or has any rights with respect to or arising from, any Contract with Purchaser or its
Subsidiaries that has not been publicly disclosed in Purchaser’s filings with the SEC.


 




    6


     


    

 


(g)   
Acknowledgment. Such Sponsor understands and acknowledges that each of Purchaser and the Company is entering into the BCA
in reliance upon such Sponsor’s execution and delivery of this Agreement.


 


(h)   
Certain Securities Law Representations and Warranties.


 


(i)
Such Sponsor has never been suspended or expelled from membership in any securities or commodities exchange or association or had
a securities or commodities license or registration denied, suspended or revoked;


 


(ii)
In the case of such Sponsor who is an individual, its biographical information furnished to the Company, if any (including any
such information to be included in the Registration Statement), is (or will be when furnished and thereafter) true and accurate in all
material respects and does not (or will not when furnished and thereafter) omit any material information with respect to such Sponsor’s
background;


 


(iii)
Such Sponsor’s questionnaire furnished to the Company or Purchaser, if any, is (or will be when furnished and thereafter)
true and accurate in all material respects;


 


(iv)
Such Sponsor is not subject to or a respondent in any legal action for any injunction, cease-and-desist order or order or stipulation
to desist or refrain from any act or practice relating to the offering of securities in any jurisdiction; and


 


(v)
Such Sponsor has never been convicted of, or pleaded guilty to, any crime (A) involving any fraud, (B) relating to any financial
transaction or handling of funds of another Person or (C) pertaining to any dealings in any securities, and it is not currently a defendant
in any such criminal proceeding.


 


Section 2.2
No Actions to Breach Agreement. Each Sponsor shall not take any action that would make any representation or warranty of
such Sponsor contained herein untrue or incorrect or have the effect of preventing or disabling such Sponsor from performing its obligations
under this Agreement.


 


Section 2.3
Update of Schedule I. If any Sponsor acquires record or beneficial ownership of any Purchaser Common Stock or Purchaser
Warrants during the Interim Period (or becomes aware, during the Interim Period, of its record or beneficial ownership of any Purchaser
Common Stock or Purchaser Warrants as of the date hereof, which securities are not already set forth on Schedule I), such Sponsor shall
promptly notify the Company and Purchaser in writing, and Schedule I shall be updated to reflect such Sponsor’s ownership of such
additional Purchaser Common Stock or Purchaser Warrants, as applicable.


 






    7


     


    

 


ARTICLE
III

MISCELLANEOUS


 


Section 3.1 Termination;
Non-Survival of Representations and Warranties.


 


(a)
This Agreement shall terminate upon the earlier to occur of (i) the termination of the BCA in accordance with its terms in circumstances
where the Closing does not occur and (ii) the expiration of the Lock-up Period, and upon such termination, this Agreement shall forthwith
become void and have no further force or effect, without any liability on the part of any Party; provided, that (1) no such termination
shall relieve any Party of any liability for fraud or intentional and willful breach of this Agreement prior to its termination, and (2)
Section 1.1, Section 2.2, this Section 3.1, and Sections 3.2 through 3.9 shall survive any such termination.


 


(b)
None of the representations or warranties contained in this Agreement or in any certificate or other writing delivered pursuant
hereto shall survive the Closing.


 


Section 3.2
Capacity. Notwithstanding anything herein to the contrary, each Sponsor is signing this Agreement solely in such Sponsor’s
capacity as a shareholder of Purchaser, and not in any other capacity, and this Agreement shall not limit, prevent or otherwise affect
the actions of such Sponsor or any Affiliate or Representative thereof, or any of their respective Affiliates, in his, her or its capacity,
if applicable, as an officer or director of Purchaser or any other Person, including in the exercise of his, her or its fiduciary duties
as a director or officer of Purchaser.


 


Section 3.3
Notices. All notices, consents, waivers and other communications hereunder shall be in writing and shall be deemed to have
been duly given when delivered (i) in person, (ii) by facsimile or other electronic means (including e-mail), with affirmative confirmation
of receipt, (iii) one Business Day after being sent, if sent by reputable, nationally recognized overnight courier service or (iv) three
(3) Business Days after being mailed, if sent by registered or certified mail, pre-paid and return receipt requested, in each case to
the applicable Party at the following addresses (or at such other address for a Party as shall be specified by like notice):


 


	
    If to the Purchaser at or prior to the Closing,
    to:

     

    Quantum FinTech Acquisition Corporation

    4221 W. Boy Scout Blvd., Suite 300

    Tampa, FL 33607

    Attn: Sandip I. Patel

    E-mail: spatel@qventllc.com
	 	
    with a copy (which will not constitute notice)
    to:

     

    Winston & Strawn LLP

    200 Park Avenue

    New York, NY 10166

    Attn: Carol Anne Huff; Jason D. Osborn

    Facsimile: 212-294-4700

    Email: CHuff@winston.com;

    JOsborn@winston.com

	
    If to a Sponsor, to such Sponsor’s address
    set forth in Schedule I

     
	 	
    with a copy to (which will not constitute notice):

     

    Greenberg Traurig, LLP

    1750 Tysons Boulevard, Suite 1000

    McLean, VA 22102

    Attn: Jason Simon

    Facsimile No.: +1 703.714.8386

    Telephone No.: +1 703.749.1386

    E-mail: simonj@gtlaw.com




 






    8


     


    

 


	
    If to the Company or the Surviving Corporation,
    to:

     

    AtlasClear, Inc.

    4221 W. Boy Scout Blvd., Ste 300

    Tampa, FL 33607

    Attn: Craig Ridenhour

    Telephone No.: +1 727.512.9631

    E-mail: cridenhour@atlasbanc.com
	 	
    with a copy (which will not constitute notice)
    to:

     

    Greenberg Traurig, LLP

    1750 Tysons Boulevard, Suite 1000

    McLean, VA 22102

    Attn: Jason Simon

    Facsimile No.: +1 703.714.8386

    Telephone No.: +1 703.749.1386

    E-mail: simonj@gtlaw.com

	
    If to the Purchaser after the Closing, to:

     

    Quantum FinTech Acquisition Corporation

    4221 W. Boy Scout Blvd., Suite 300

    Tampa, FL 33607

    Attn: Sandip I. Patel

    E-mail: spatel@qventllc.com
	 	
    with a copy (which will not constitute notice)
    to:

     

    Winston & Strawn LLP

    200 Park Avenue

    New York, NY 10166

    Attn: Carol Anne Huff; Jason D. Osborn

    Facsimile: 212-294-4700

    Email: CHuff@winston.com;

    JOsborn@winston.com




 


Section 3.4
Binding Effect; Assignment. This Agreement and all of the provisions hereof shall be binding upon and inure to the benefit
of the Parties hereto and their respective successors and permitted assigns. This Agreement shall not be assigned by operation of Law
or otherwise without the prior written consent of the Purchaser and the Company, and any assignment without such consent shall be null
and void; provided that no such assignment shall relieve the assigning Party of its obligations hereunder.


 


Section 3.5
Third Parties. Nothing contained in this Agreement or in any instrument or document executed by any party in connection
with the transactions contemplated hereby shall create any rights in, or be deemed to have been executed for the benefit of, any Person
that is not a Party hereto or thereto or a successor or permitted assign of such a Party.


 


Section 3.6 Governing Law;
Jurisdiction. This Agreement shall be governed by, construed and enforced in accordance with the Laws of the State of New Delaware
without regard to the conflict of laws principles thereof. All Actions arising out of or relating to this Agreement shall be heard and
determined exclusively in the Court of Chancery of the State of Delaware located in Wilmington, Delaware (and in the absence of jurisdiction,
the Parties consent to be subject to the jurisdiction of the United States District Court for the District of Delaware or any other state
court located in Wilmington, Delaware) (the “Specified Courts”). Each Party hereto hereby (a) submits to the exclusive
jurisdiction of any Specified Court for the purpose of any Action arising out of or relating to this Agreement brought by any Party hereto
and (b) irrevocably waives, and agrees not to assert by way of motion, defense or otherwise, in any such Action, any claim that it is
not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution,
that the Action is brought in an inconvenient forum, that the venue of the Action is improper, or that this Agreement or the transactions
contemplated hereby may not be enforced in or by any Specified Court. Each Party agrees that a final judgment in any Action shall be
conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by Law. Each Party irrevocably
consents to the service of the summons and complaint and any other process in any other Action relating to the transactions contemplated
by this Agreement, on behalf of itself, or its property, by personal delivery of copies of such process to such Party at the applicable
address set forth in Section 3.3. Nothing in this Section 3.6 shall affect the right of any Party to serve legal process
in any other manner permitted by Law.


 




    9


     


    

 


Section 3.7
WAIVER OF JURY TRIAL. EACH PARTY HERETO HEREBY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW ANY RIGHT IT MAY
HAVE TO A TRIAL BY JURY WITH RESPECT TO ANY ACTION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR
THE TRANSACTIONS CONTEMPLATED HEREBY. EACH PARTY HERETO (A) CERTIFIES THAT NO REPRESENTATIVE OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY
OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF ANY ACTION, SEEK TO ENFORCE THAT FOREGOING WAIVER AND (B) ACKNOWLEDGES
THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS
IN THIS SECTION 3.7.


 


Section 3.8
Specific Performance. Each Party acknowledges that the rights of each Party to consummate the transactions contemplated
hereby are unique, recognizes and affirms that in the event of a breach of this Agreement by any Party, money damages may be inadequate
and the non-breaching Parties may have not adequate remedy at law, and agree that irreparable damage would occur in the event that any
of the provisions of this Agreement were not performed by an applicable Party in accordance with their specific terms or were otherwise
breached. Accordingly, each Party shall be entitled to seek an injunction or restraining order to prevent breaches of this Agreement and
to seek to enforce specifically the terms and provisions hereof, without the requirement to post any bond or other security or to prove
that money damages would be inadequate, this being in addition to any other right or remedy to which such Party may be entitled under
this Agreement, at law or in equity.


 


Section 3.9
Severability. In case any provision in this Agreement shall be held invalid, illegal or unenforceable in a jurisdiction,
such provision shall be modified or deleted, as to the jurisdiction involved, only to the extent necessary to render the same valid, legal
and enforceable, and the validity, legality and enforceability of the remaining provisions hereof shall not in any way be affected or
impaired thereby nor shall the validity, legality or enforceability of such provision be affected thereby in any other jurisdiction. Upon
such determination that any term or other provision is invalid, illegal or incapable of being enforced, the Parties will substitute for
any invalid, illegal or unenforceable provision a suitable and equitable provision that carries out, so far as may be valid, legal and
enforceable, the intent and purpose of such invalid, illegal or unenforceable provision.


 


Section 3.10
Amendment. This Agreement may be amended, supplemented or modified only by execution of a written instrument signed by the
Purchaser and the Company.


 


Section 3.11 Waiver.
The Purchaser on behalf of itself and its Affiliates, and the Company on behalf of itself and its Affiliates, may in its sole
discretion (i) extend the time for the performance of any obligation or other act of any other non-Affiliates hereto, (ii) waive any
inaccuracy in the representations and warranties by such other non-Affiliates Party contained herein or in any document delivered
pursuant hereto and (iii) waive compliance by such other non-Affiliates with any covenant or condition contained herein. Any such
extension or waiver shall be valid only if set forth in an instrument in writing signed by the Party or Parties to be bound thereby.
Notwithstanding the foregoing, no failure or delay by a Party in exercising any right hereunder shall operate as a waiver thereof
nor shall any single or partial exercise thereof preclude any other or further exercise of any other right hereunder.


 






    10


     


    

 


Section 3.12
Entire Agreement. This Agreement, the BCA and the documents or instruments referred to herein, including any exhibits and
schedules attached hereto, which exhibits and schedules are incorporated herein by reference, together with the Ancillary Documents, embody
the entire agreement and understanding of the Parties hereto in respect of the subject matter contained herein. There are no restrictions,
promises, representations, warranties, covenants or undertakings, other than those expressly set forth or referred to herein or the documents
or instruments referred to herein, which collectively supersede all prior agreements and the understandings among the Parties with respect
to the subject matter contained herein..


 


[THE REMAINDER OF THIS PAGE IS INTENTIONALLY
BLANK]


 




    11


     


    

 


IN WITNESS WHEREOF, the Sponsors,
Purchaser, and the Company have each caused this Agreement to be duly executed as of the date first written above.


 


	 	SPONSORS:
	 	 
	 	QUANTUM VENTURES LLC
	 	 	 
	 	By:	/s/ John Schaible
	 	 	Name:	John Schaible
	 	 	Title:	Chief Executive Officer



 


	 	/s/ John Schaible
	 	Name:	John Schaible
	 	 	 
	 	/s/ Miguel Leon
	 	Name:	Miguel Leon
	 	 	 
	 	/s/ Sandip I. Patel
	 	Name:	Sandip I. Patel
	 	 	 
	 	/s/ Thomas J. Hammond
	 	Name:	Thomas J. Hammond
	 	 	 
	 	/s/ Richard Korhammer
	 	Name:	Richard Korhammer
	 	 	 
	 	/s/ Steven J. Carlson
	 	Name:	Steven J. Carlson 
	 	 	 
	 	/s/ Michael Devlin
	 	Name:	Michael Devlin



 


[Signature Page to Purchaser Support Agreement] 


 




     


     


    

 


	 	PURCHASER:
	 	 
	 	QUANTUM FINTECH ACQUISITION CORPORATION
	 	 	 	 
	 	By:	/s/ John Schaible
	 	 	Name:	John Schaible
	 	 	Title:	Chief Executive Officer



 


[Signature Page to Purchaser Support Agreement] 


 





     


     


    

 


	 	COMPANY:
	 	 
	 	ATLASCLEAR, INC.
	 	 	 
	 	By:	/s/ Craig Ridenhour
	 	 	Name:	Craig Ridenhour
	 	 	Title:	Chief Business Development Officer



 


[Signature Page to Sponsor Support Agreement] 


 




     


     


    

 


Schedule I


Sponsor-held Purchaser Common Stock and Purchaser
Warrants


 


	Sponsor	 	Purchaser Common Stock	 	 	Purchaser Warrants	 
	Quantum Ventures LLC 
  
4221 W. Boy Scout Blvd., Suite 300, Tampa, FL 33607	 	 	3,796,335	 	 	 	4,922,500	 
	Chardan Quantum LLC 
17 State Street, New York, NY 10004	 	 	949,084	 	 	 	1,230,625	 
	John Schaible 
  
c/o Quantum Ventures LLC 
4221 W. Boy Scout Blvd., Suite 300, Tampa, FL 33607	 	 	40,833	 	 	 	0	 
	Miguel Leon 
  
c/o Quantum Ventures LLC 
4221 W. Boy Scout Blvd., Suite 300, Tampa, FL 33607	 	 	40,833	 	 	 	0	 
	Daniel Caamano, V 
  
c/o Quantum Ventures LLC 
4221 W. Boy Scout Blvd., Suite 300, Tampa, FL 33607	 	 	41,233	 	 	 	0	 
	Sandip I. Patel 
  
c/o Quantum Ventures LLC 
4221 W. Boy Scout Blvd., Suite 300, Tampa, FL 33607	 	 	41,334	 	 	 	0	 
	Thomas J. Hammond 
  
c/o Quantum Ventures LLC 
4221 W. Boy Scout Blvd., Suite 300, Tampa, FL 33607	 	 	40,833	 	 	 	0	 
	Richard Korhammer 
  
c/o Quantum Ventures LLC 
4221 W. Boy Scout Blvd., Suite 300, Tampa, FL 33607	 	 	40,833	 	 	 	0	 
	Steven J. Carlson 
  
c/o Quantum Ventures LLC 
4221 W. Boy Scout Blvd., Suite 300, Tampa, FL 33607	 	 	40,833	 	 	 	0	 



 


[Schedule I to Sponsor Support Agreement]


 





     


     


    

 


Schedule II


 


Affiliate Agreements


 


		1.	Registration and Stockholder Rights Agreement, dated February 4, 2021, by and between Quantum, Sponsor
and each of the executive officers and directors of Quantum



 


		2.	Stock Escrow Agreement, dated February 4, 2021, by and between Quantum, Continental Stock Transfer &
Trust Company, Sponsor and each of the executive officers and directors of Quantum



 


		3.	Subscription Agreement, dated October 23, 2020, by and between Quantum and Quantum Ventures LLC



 


		4.	Promissory Note, dated October 1, 2020, issued to Quantum Ventures LLC



 


		5.	Business Combination Marketing Agreement, dated February 4, 2021, by and between Quantum and Chardan Capital
Markets LLC



 


		6.	Insider Letter (Co-Sponsors), dated as of February 4, 2021, by and between Quantum and Sponsor



 


		7.	Insider Letter, dated as of February 4, 2021, by and between Quantum and each of the executive officers
and directors of Quantum



 


		8.	Private Placement Warrants Purchase Agreement, dated February 4, 2021, by and between Quantum and Quantum
Ventures LLC



 


		9.	Private Placement Warrants Purchase Agreement, dated February 4, 2021, by and between Quantum, Chardan
Capital Markets, LLC and B. Riley Securities, Inc.



 


		10.	Underwriting Agreement, dated as of February 4, 2021, by and between Quantum, Chardan Capital Markets,
LLC and B. Riley Securities, Inc.



 


		11.	Administrative Service Agreement, dated as of February 4, 2021, by and between Quantum and Quantum Ventures
LLC



 


		12.	Co-Placement Joinder dated September 13, 2021 by and between PSC, Quantum and Chardan Capital Markets
LLC, to the Letter agreement for lead placement agent services, dated August 20, 2021, by and between Quantum and PSC.



 


		13.	Letter Agreement, dated November 9, 2021, between Quantum and Chardan.



 


		14.	Indemnification Agreements with each of the executive officers and directors of Quantum



 


		a.	Indemnity Agreement, dated February 4, 2021, by and between Quantum and Miguel Leon



 




     


     


    

 


		b.	Indemnity Agreement, dated February 4, 2021, by and between Quantum and Richard Korhammer



 


		c.	Indemnity Agreement, dated February 4, 2021, by and between Quantum and Sandip I. Patel



 


		d.	Indemnity Agreement, dated February 4, 2021, by and between Quantum and Steven Carlson



 


		e.	Indemnity Agreement, dated February 4, 2021, by and between Quantum and John M. Schaible



 


		f.	Indemnity Agreement, dated February 4, 2021, by and between Quantum and Thomas Hammond